Suppr超能文献

商陆根提取物诱导奥沙利铂耐药大肠癌细胞发生铁死亡

Induction of ferroptosis in oxaliplatin-resistant colorectal cancer cells by extract from Planch radix.

作者信息

Lu Jun, Wang Yuhuan, Cui Wei, Ma Chenyang

机构信息

Department of Colorectal Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China.

General Surgery Department II, Fenghua District People's Hospital, Ningbo, China.

出版信息

Transl Cancer Res. 2025 Mar 30;14(3):1942-1951. doi: 10.21037/tcr-2024-2567. Epub 2025 Mar 27.

Abstract

BACKGROUND

Colorectal cancer (CRC) is the third most common cancer worldwide, and there is growing number of reports on the emergence of chemoresistance among patients with CRC. Oxaliplatin, a common chemotherapeutic agent used to treat CRC, has been linked to the emergence of drug-resistant tumor cells. While traditional Chinese medicines have gained attention for their multi-target anticancer properties, Planch radix, despite its documented anti-inflammatory and hepatoprotective effects, remains unexplored in the context of oxaliplatin resistance modulation. This study aims to investigate whether Planch radix extract can reverse oxaliplatin resistance in CRC cells and determine its mechanistic relationship with ferroptosis-an iron-dependent form of regulated cell death implicated in chemoresistance.

METHODS

Oxaliplatin-resistant HT29 CRC cells were generated by increasing the concentration of oxaliplatin in the culture media. Cell viability was measured via MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium-bromide) assay, while proliferation was assessed via wound healing assays. Gene expression was determined with quantitative polymerase chain reaction and Western blotting. Extract from Planch radix was achieved by hydrophilic extraction.

RESULTS

Treatment with Planch radix extract significantly inhibited the overgrowth of oxaliplatin-resistant HT29 cells, suggesting a potential reversal of chemoresistance. The extract induced ferroptosis, a type of programmed cell death dependent on iron and characterized by lipid peroxidation in oxaliplatin-resistant HT29 cells. The extract modified the expression of several key genes and proteins associated with chemoresistance and cell survival, including ubiquitin-specific-processing protease 7 (), wild-type tumor suppressor protein 53 (), and transferrin receptor 1 (). Changes were observed at both the messenger RNA and protein levels, indicating a direct regulatory effect.

CONCLUSIONS

Planch radix extract effectively reverses oxaliplatin resistance in CRC cells by inducing ferroptosis and modulating the expression of crucial genes including as , wild-type , and . These findings suggest that this traditional Chinese medicine could be a promising therapeutic agent to overcome chemoresistance in CRC.

摘要

背景

结直肠癌(CRC)是全球第三大常见癌症,关于CRC患者中化疗耐药性出现的报道越来越多。奥沙利铂是一种用于治疗CRC的常见化疗药物,与耐药肿瘤细胞的出现有关。虽然中药因其多靶点抗癌特性而受到关注,但尽管有文献记载了板蓝根具有抗炎和保肝作用,但在奥沙利铂耐药调节方面仍未得到探索。本研究旨在探讨板蓝根提取物是否能逆转CRC细胞中的奥沙利铂耐药性,并确定其与铁死亡(一种与化疗耐药性有关的铁依赖性程序性细胞死亡形式)的机制关系。

方法

通过增加培养基中奥沙利铂的浓度来产生奥沙利铂耐药的HT29 CRC细胞。通过MTT(3-[4,5-二甲基噻唑-2-基]-2,5-二苯基四氮唑溴盐)法测量细胞活力,通过伤口愈合试验评估细胞增殖。用定量聚合酶链反应和蛋白质印迹法测定基因表达。板蓝根提取物通过亲水提取获得。

结果

板蓝根提取物处理显著抑制了奥沙利铂耐药的HT29细胞的过度生长,表明化疗耐药性可能得到逆转。该提取物诱导了铁死亡,这是一种依赖铁的程序性细胞死亡类型,其特征是奥沙利铂耐药的HT29细胞中发生脂质过氧化。该提取物改变了几个与化疗耐药性和细胞存活相关的关键基因和蛋白质的表达,包括泛素特异性加工蛋白酶7()、野生型肿瘤抑制蛋白53()和转铁蛋白受体1()。在信使核糖核酸和蛋白质水平均观察到变化,表明有直接的调节作用。

结论

板蓝根提取物通过诱导铁死亡和调节包括、野生型和等关键基因的表达,有效逆转了CRC细胞中的奥沙利铂耐药性。这些发现表明,这种中药可能是克服CRC化疗耐药性的一种有前景的治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ad6/11985198/2725b721da48/tcr-14-03-1942-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验